GKOS
Glaukos Corporation
NYSE · USHealthcareMedical - Devices
$155.46-0.87%
Price as of Jul 20, 2026
GKOS valuation
Glaukos Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 2591.00x
- P/E 2026E
- —
- P/E 2027E
- 370.98x
- P/E 2028E
- 95.35x
- P/S forward
- 13.24x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.61x
- Price / sales
- 16.56x
- Price / cash flow
- -1038.30x
Enterprise value
- Enterprise value
- $9.0B
- EV / sales
- 16.25x
- EV / EBITDA
- -62.20x
- EV / EBIT
- -104.26x
- Market cap
- $9.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.